2016 annual financial data
Cartesian Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -243.51%.
Operating income was -34,670,000 USD and net income was -36,210,000 USD.
Operating cash flow was -19,683,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,083,000 USD
- Operating income
- -34,670,000 USD
- Net income
- -36,210,000 USD
- Operating cash flow
- -19,683,000 USD